XML 23 R2.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Dec. 31, 2019
Dec. 31, 2018
Real estate properties:    
Land $ 793,123 $ 844,567
Buildings and improvements 6,668,463 7,031,733
Total real estate properties, gross 7,461,586 7,876,300
Accumulated depreciation (1,570,801) (1,534,392)
Total real estate properties, net 5,890,785 6,341,908
Assets of properties held for sale 209,570 1,928
Cash and cash equivalents 37,357 54,976
Restricted cash [1] 14,867 15,095
Investments in equity securities 1,571 142,027
Due from affiliates 1,990 18,701
Acquired real estate leases and other intangible assets, net 337,875 419,244
Other assets, net 159,811 166,547
Total assets 6,653,826 7,160,426
LIABILITIES AND SHAREHOLDERS' EQUITY    
Unsecured revolving credit facility 537,500 139,000
Unsecured term loans, net 448,741 548,286
Senior unsecured notes, net 1,820,681 2,216,945
Secured debt and capital leases, net 694,739 744,186
Liabilities of properties held for sale 6,758 0
Accrued interest 24,060 26,182
Due to affiliates 8,779 54,299
Assumed real estate lease obligations, net 76,705 86,304
Other liabilities 158,813 165,354
Total liabilities 3,776,776 3,980,556
Commitments and contingencies
Equity attributable to common shareholders:    
Common shares of beneficial interest, $.01 par value: 300,000,000 shares authorized, 237,897,163 and 237,729,900 shares issued and outstanding at December 31, 2019 and 2018, respectively 2,379 2,377
Additional paid in capital 4,612,511 4,611,419
Cumulative net income 2,052,562 2,140,796
Cumulative other comprehensive loss 0 (266)
Cumulative distributions (3,930,933) (3,731,214)
Total equity attributable to common shareholders 2,736,519 3,023,112
Noncontrolling interest:    
Total equity attributable to noncontrolling interest 140,531 156,758
Total equity 2,877,050 3,179,870
Total liabilities and equity $ 6,653,826 $ 7,160,426
[1] Restricted cash consists of amounts escrowed for real estate taxes, insurance and capital expenditures at certain of our mortgaged properties and cash held for the operations of one of our life science properties that is owned in a joint venture arrangement in which we own a 55% equity interest.